VAP Diagnostics Lab
Daniel Martz is a Clinical Research Coordinator at Atherotech since September 2011, where responsibilities include collaborating with the Principal Investigator on IRB document submissions, developing internal research procedures, and maintaining essential study documentation. Prior to this role, Daniel served as a Corporate Data Analyst for Career Services at Education Corporation of America from March 2009 to September 2011, focusing on corporate management and analysis of placement trends for over 80 campus Career Services personnel. Daniel holds a Bachelor's Degree in Social Work from the University of Alabama at Birmingham and a Master's Degree in Public Health from the University of West Florida.
This person is not in any teams
VAP Diagnostics Lab
VAP Diagnostics Lab is a clinical reference laboratory focusing on cardiometabolic health and disease management solutions. Our proprietary test, the VAP+ Lipid Panel, provides a direct measurement of the comprehensive lipid profile by using a patented density gradient ultracentrifugation. VAP Diagnostics provides its unique testing services to physicians, hospitals, clinics, and other laboratories throughout the United States. About The VAP+ Lipid Panel The VAP+ Lipid Panel is an expanded cholesterol profile that provides direct, detailed measurements of cholesterol, or lipid, subclasses, which play important roles in the development of cardiovascular disease, the No. 1 cause of death in the United States. The test identifies a far greater number of people at risk for heart disease than traditional cholesterol tests developed in the 1970s. Measurements obtained using The VAP+ also provide doctors with a foundation from which to develop individualized treatment plans while continuing to track patients' progress in battling heart disease. The price of the VAP+ is comparable to the traditional cholesterol test.